Other
Other sodium sulphites (inorganic sulphite salts)
HSN 2832 10 90 (Other sodium sulphites) is subject to Central Board of Indirect Taxes and Customs (CBIC) mandatory Chapter 28 additional-qualifier requirements at the bill-of-entry stage under CBIC Circular 23/2023-Cus dated 30-09-2023. Where the sodium sulphite is classified as a drug or pharmaceutical intermediate, five mandatory documents — including a registration certificate and import licence for drugs — must be uploaded in e-Sanchit before out-of-charge.
- Certificate of analysis from supplier
- Registration certificate from CDSCO
- Import licence from CDSCO
- 1Declare all mandatory additional qualifiers in the import declaration for Chapter 28 commodities as stipulated in paragraphs 4.1 and 4.2 of CBIC Circular 23/2023-Cus, with effect from 15 October 2023. Failure to include the required qualifiers renders the bill of entry deficient and liable to detention pending amendment.CBIC Circular 23/2023-Cus dated 30-09-2023, Para 4.1 and 4.2
- 2Where the sodium sulphite consignment is classified as a drug or pharmaceutical intermediate, upload in e-Sanchit all five mandatory documents before filing the bill of entry: certificate of analysis — drug (0010dc), batch release certificate (0030dc), label of consignment (0110dc), registration certificate for drugs (101dc1), and import licence for drugs (9111dc).CBIC Circular 23/2023-Cus dated 30-09-2023 · e-Sanchit document codes 0010dc, 0030dc, 0110dc, 101dc1, 9111dc
The most common error on this tariff line is treating the drug-document requirement as universal rather than conditional on end-use classification: importers of industrial-grade sodium sulphite (used in water treatment, photography, or paper manufacture) are not required to upload drug-regime documents, whereas the same molecule imported as a pharmaceutical intermediate or active pharmaceutical ingredient triggers all five document codes. Misclassifying the end-use in either direction — uploading unnecessary drug documents for an industrial consignment or omitting them for a pharmaceutical one — causes e-Sanchit verification failures and out-of-charge delays.